UNSPSC 51282610: Cefepime hydrochloride

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I8X1O0607P. European Medicines Agency schedules Cefepime dihydrochloride monohydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26333. Cefepime hydrochloride generally arises in the molecular formula C19H24N6O5S2.2CLH.H2O. The term 'cefepime hydrochloride' is a European Pharmacopoeia designation.

Most nations, for tariff and trade purposes, schedule cefepime hydrochloride under HS 29419000 and SITC 54139. As of Q4 2014, CEFEPIME HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Cefepime hydrochloride bears US NLM identifiers UMLS ID C0771284 and NCI Concept Code C1041. SMILES: C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4CSC(N4)N)SC2)C(=O)[O-].O.CL.CL.

UNSPSC 51282610 Cefepime hydrochloride is a Commodity code that nominally designates a specific injectable antibiotic product, yet recent state and local solicitations tagged to this code show little alignment with that narrow pharmaceutical scope. The recent opportunities posted under this code instead span naloxone procurement, direct-to-manufacturer prescription program planning, general medical and first aid supplies for emergency response, and multi-source generic pharmaceutical contracting through cooperative purchasing. The issuing bodies include county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances administering multi-state contracts. The work being solicited ranges from consumable medical supply procurement for emergency medical services to strategic pharmacy benefit program development and manufacturer-direct contracting models.

The geographic spread includes Florida (Seminole County), Texas (Texas Health and Human Services Commission), and the Upper Midwest through the Minnesota Multistate Cooperative Purchasing Alliance, which serves multiple states including Oregon. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries and a sheltered-market award to lowest responsible bidder; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies totaling approximately $700,000 and restricted to certified Small Local Business Enterprises with a 5 percent bid discount; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing multi-source generic pharmaceutical and OTC product contracts across state and local facilities with awards effective July 1, 2026. The code shows substantial misalignment between its nominal Cefepime scope and actual procurement activity, limiting relevance for vendors focused on that specific antibiotic product line.